Wall Street analysts expect PulteGroup (PHM) to post quarterly earnings of $2.93 per share in its upcoming report, which indicates a year-over-year decline of 18.2%. Revenues are expected to be $4.39 billion, down 4.5% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings announcement, it is crucial to con ...

Core Viewpoint - Astrana Health, Inc. (ASTH) shows significant upside potential with a mean price target of $49.56, indicating a 97.3% increase from the current price of $25.12 [1] Price Targets and Analyst Consensus - The average price target consists of nine estimates ranging from a low of $36.00 to a high of $70.00, with a standard deviation of $12.39, suggesting variability in analyst opinions [2] - The lowest estimate indicates a potential increase of 43.3%, while the highest suggests a 178.7% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about ASTH's earnings prospects, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, two estimates have been revised upward, leading to a 46.4% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - ASTH holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14]

Core Insights - Autoliv, Inc. (ALV) is expected to report quarterly earnings of $2.07 per share, reflecting a 10.7% increase year-over-year, with revenues projected at $2.63 billion, a 0.8% increase from the previous year [1] - Analysts have revised the consensus EPS estimate upward by 0.7% over the past 30 days, indicating a collective reassessment of projections [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock price performance [3] Financial Metrics - Analysts estimate 'Net Sales- Seatbelt Products and Other' to reach $839.37 million, indicating a -2.2% change year-over-year [5] - 'Net Sales- Airbags, Steering Wheels and Other' is projected at $1.76 billion, reflecting a +0.5% change from the prior year [5] - 'Net Sales- Americas' is expected to be $855.27 million, showing a -4.2% change from the previous year [5] - 'Net Sales- Europe' is forecasted at $751.53 million, indicating a -1.2% change year-over-year [6] - 'Net Sales- Asia excl. China' is estimated to reach $499.63 million, reflecting a +3.4% change [6] - 'Net Sales- China' is projected at $488.36 million, indicating a +4.4% change from the prior year [6] Stock Performance - Autoliv shares have increased by +5.6% over the past month, compared to a +5% increase in the Zacks S&P 500 composite [6] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6]

Core Viewpoint - Analysts project that Huntington Bancshares (HBAN) will report quarterly earnings of $0.34 per share, reflecting a year-over-year increase of 13.3% and revenues of $1.98 billion, up 9.2% from the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted upward by 1.2%, indicating a collective reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [3]. Key Metrics Forecast - Analysts estimate the 'Efficiency Ratio' to be 60.4%, slightly improved from 60.8% a year ago [5]. - The 'Average Balance - Total earning assets' is projected at $191.10 billion, compared to $178.06 billion last year [5]. - The 'Tier 1 Leverage Ratio' is expected to be 8.4%, down from 8.8% a year ago [5]. - The 'Regulatory Tier 1 risk-based capital ratio' is estimated at 12.0%, slightly lower than the 12.1% reported in the same quarter last year [6]. Revenue Projections - 'Total Non-Interest Income' is expected to reach $520.55 million, up from $491.00 million in the same quarter last year [6]. - 'Mortgage banking income' is projected at $33.96 million, compared to $30.00 million a year ago [7]. - 'Customer deposit and loan fees' are expected to be $88.58 million, up from $83.00 million last year [7]. - 'Payments and cash management revenue' is forecasted at $162.96 million, compared to $154.00 million last year [8]. - 'Wealth and asset management revenue' is estimated at $103.61 million, up from $90.00 million a year ago [8]. - 'Capital markets and advisory fees' are expected to reach $76.17 million, compared to $73.00 million last year [9]. - 'Net interest income - FTE' is projected at $1.47 billion, up from $1.33 billion a year ago [9]. - 'Leasing revenue' is expected to be $15.53 million, down from $19.00 million last year [9]. Stock Performance - Huntington Bancshares shares have increased by 8.7% over the past month, outperforming the Zacks S&P 500 composite's 5% increase, with a Zacks Rank 2 (Buy) indicating expected outperformance in the near term [11].

Core Insights - Analysts project that The Charles Schwab Corporation (SCHW) will report quarterly earnings of $1.08 per share, reflecting a 48% year-over-year increase. Revenues are expected to reach $5.67 billion, marking a 20.8% increase from the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been revised upward by 2.2%, indicating a collective reassessment by covering analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Key Financial Metrics - Analysts estimate 'Net Revenues - Net interest revenue' at $2.73 billion, a 26.5% increase from the previous year [5]. - 'Net Revenues - Other' is projected to be $212.08 million, reflecting a 3.2% decrease from the prior year [5]. - 'Net Revenues - Bank deposit account fees' are expected to reach $243.02 million, indicating a significant increase of 58.8% from the prior year [5]. - 'Net Revenues - Asset management and administration fees' are forecasted at $1.56 billion, a 12.9% increase year-over-year [6]. - Total client assets are projected to reach $10,444.09 billion, up from $9,407.50 billion a year ago [6]. Client Activity and Assets - 'Clients' Daily Average Trades (DATs)' are expected to be 7.15 million, compared to 5.49 million in the previous year [7]. - 'Average Interest Earning Assets' are projected to be $421.33 billion, slightly up from $418.97 billion year-over-year [7]. - 'Average Client Assets - Total managed investing solutions' are estimated at $686.27 million, compared to $635.92 million in the same quarter last year [8]. - 'Average Client Assets - Mutual Fund OneSource and other no-transaction-fee funds' are expected to reach $349.81 million, up from $338.20 million year-over-year [8]. - 'Average Client Assets - Schwab equity and bond funds, ETFs, and CTFs' are projected at $652.93 million, compared to $565.85 million last year [9]. - 'Average Client Assets - Schwab money market funds' are expected to be $651.07 million, up from $523.67 million in the same quarter last year [9]. - 'Net new client assets' are estimated at $95.09 billion, compared to $74.20 billion a year ago [10]. Stock Performance - Shares of Charles Schwab have increased by 4.2% over the past month, compared to a 5% increase in the Zacks S&P 500 composite [11].

Core Viewpoint - Analysts project that Regions Financial (RF) will report quarterly earnings of $0.56 per share, reflecting a year-over-year increase of 7.7% and revenues of $1.85 billion, up 7.1% from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 1.5% in the past 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Financial Metrics - Analysts expect the 'Net interest margin (FTE)' to reach 3.6%, up from 3.5% in the same quarter last year [5]. - The 'Efficiency Ratio' is projected at 56.9%, compared to 57.6% a year ago [5]. - The 'Common Equity Tier 1 ratio' is anticipated to be 10.7%, an increase from 10.4% year-over-year [5]. Asset and Income Projections - The 'Average Balance - Total earning assets' is expected to be $139.69 billion, up from $137.07 billion last year [6]. - 'Non-performing assets' are projected at $899.10 million, compared to $862.00 million a year ago [6]. - 'Total Non-Interest Income' is likely to reach $621.40 million, up from $545.00 million last year [8]. - 'Net Interest Income' is expected to be $1.20 billion, slightly up from $1.19 billion year-over-year [8]. Additional Financial Insights - The consensus estimate for 'Net interest income, taxable equivalent basis' stands at $1.24 billion, compared to $1.20 billion last year [9]. - 'Wealth management income' is estimated at $127.46 million, up from $122.00 million in the same quarter of the previous year [9]. - Regions Financial shares have returned +13.9% over the past month, outperforming the Zacks S&P 500 composite's +5% change [9].

Core Viewpoint - Analysts project that American Express (AXP) will report quarterly earnings of $3.86 per share, reflecting a year-over-year increase of 10.6%, with revenues expected to reach $17.69 billion, an 8.3% increase from the same quarter last year [1] Earnings Estimates - There have been no revisions in the consensus EPS estimate for the quarter over the last 30 days, indicating stability in analysts' forecasts [1][2] Key Metrics Projections - The consensus estimate for 'Book value per common share' is $44.84, up from $39.26 in the same quarter last year [4] - 'Risk-Based Capital - Common Equity Tier 1' is projected to be 10.5%, slightly down from 10.8% in the same quarter of the previous year [4] Commercial Services Metrics - 'Commercial Services - Card Member Loans - Total loans' are expected to reach $32.53 billion, compared to $28.62 billion in the same quarter last year [5] - 'Commercial Services - Card Member loans - Average Loans' is projected at $31.83 billion, up from $28.03 billion in the same quarter last year [5] International Card Services Metrics - 'International Card Services - Card Member loans - consumer and small business - Average loans' is forecasted to be $17.98 billion, compared to $16.84 billion in the same quarter last year [6] - 'International Card Services - Card Member loans - consumer and small business - Total loans' is expected to reach $18.50 billion, up from $17.27 billion a year ago [6] U.S. Consumer Services Metrics - 'U.S. Consumer Services - Card Member loans - Total loans' is projected at $92.66 billion, compared to $84.96 billion in the same quarter last year [7] - 'Card billed business (Network volumes)' is expected to reach $465.80 billion, up from $440.60 billion a year ago [7] Average Card Member Loans - 'Average Card Member loans' is expected to be $141.10 billion, compared to $128.32 billion in the same quarter last year [8] - 'Total Card Member loans' is projected at $143.69 billion, up from $130.85 billion in the same quarter last year [8] Non-Interest Revenues - 'Total non-interest revenues' are projected to reach $13.40 billion, compared to $12.60 billion in the same quarter last year [9] Stock Performance - Shares of American Express have returned +9.1% over the past month, outperforming the Zacks S&P 500 composite's +5% change [10]

Core Viewpoint - PepsiCo is expected to report a decline in quarterly earnings and revenues, with earnings per share projected at $2.03, down 11% year-over-year, and revenues forecasted at $22.37 billion, a decrease of 0.6% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.1% in the last 30 days, indicating a reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts project 'Net Revenue- PBNA (PepsiCo Beverages North America)' to reach $6.84 billion, reflecting a year-over-year increase of 0.5% [5]. - 'Net Revenue- PFNA (PepsiCo Foods North America)' is estimated at $6.40 billion, indicating a significant year-over-year increase of 1040.2% [5]. - 'Net Revenue- LatAm Foods' is expected to be $2.50 billion, showing a year-over-year decline of 17.8% [5]. Stock Performance - PepsiCo shares have increased by 3.2% over the past month, compared to a 5% increase in the Zacks S&P 500 composite [6]. - With a Zacks Rank of 3 (Hold), PepsiCo is anticipated to closely follow overall market performance in the near term [6].

Wall Street analysts expect Netflix (NFLX) to post quarterly earnings of $7.05 per share in its upcoming report, which indicates a year-over-year increase of 44.5%. Revenues are expected to be $11.05 billion, up 15.6% from the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a ...

Core Viewpoint - Abbott (ABT) is expected to report quarterly earnings of $1.25 per share, reflecting a 9.7% increase year-over-year, with revenues projected at $11.07 billion, a 6.7% increase compared to the previous year [1]. Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [2]. Key Metrics Forecast - Analysts predict 'Net sales- Nutrition' to reach $2.24 billion, indicating a 4.3% increase from the prior year [4]. - The consensus for 'Net sales- Medical Devices- Diabetes Care' is $1.94 billion, reflecting a 17.5% year-over-year change [4]. - 'Net sales- Diagnostics' is expected to reach $2.22 billion, showing a 1% increase from the previous year [4]. - 'Net sales- Established Pharmaceuticals' is forecasted at $1.37 billion, a 6.1% increase year-over-year [5]. - 'Net sales- Diagnostics- U.S.' is estimated at $832.19 million, indicating a 2.5% increase [5]. - 'Net sales- Diagnostics- International' is projected to be $1.38 billion, reflecting a 0.1% increase [5]. - 'Net sales- Nutrition- International' is expected to reach $1.26 billion, a 3.5% year-over-year change [6]. - 'Net sales- Nutrition- U.S.' is forecasted at $985.20 million, indicating a 5.6% increase [6]. - 'Net sales- Medical Devices- Neuromodulation- International' is estimated at $53.47 million, reflecting a 4.8% increase [7]. - 'Net sales- Medical Devices- Rhythm Management- U.S.' is projected at $312.05 million, indicating a 6.9% increase [7]. - 'Net sales- Medical Devices- Rhythm Management- International' is expected to reach $334.64 million, reflecting a 6.2% year-over-year change [8]. - 'Net sales- Medical Devices- Structural Heart- U.S.' is forecasted at $304.28 million, indicating a 17.9% increase [8]. Stock Performance - Abbott shares have decreased by 2.7% over the past month, contrasting with the Zacks S&P 500 composite's 4% increase, but the company holds a Zacks Rank 2 (Buy), suggesting expected outperformance in the near term [8].